| 77.07 Delayed Data As of Nov 21 |  -0.36 / -0.46%Today’s Change | 62.88 Today|||52-Week Range 100.13 | -9.49% Year-to-Date |
| 2 Beaten-Down Biotech Stocks That Could Make You Rich Nov 11 / MotleyFool.com - Paid Partner Content |
| Previous close | 77.43 |
| Today’s open | 77.28 |
| Day’s range | 76.21 - 77.36 |
| Volume | 1,745,132 |
| Average volume (3 months) | 1,356,650 |
| Market cap | $13.5B |
| Earnings growth (last year) | +34.91% |
| Earnings growth (this year) | +38.96% |
| Earnings growth (next 5 years) | +52.10% |
| Revenue growth (last year) | +13.51% |
| P/E ratio | NM |
| Price/Sales | 10.07 |
| Price/Book | 4.51 |
| Today’s change | Today’s % change | |
|---|---|---|
| EXASExact Sciences Corp | -4.91 | -5.85% |
| NBIXNeurocrine Bioscienc... | +0.67 | +0.59% |
| TECHBio-Techne Corp | -3.44 | -1.58% |
| MRNAModerna Inc | +0.02 | +0.10% |
| Next reporting date | February 24, 2020 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | -$77.2M |
| Net profit margin | -5.16% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Rafael, California |
